Clinical trial
A 2-Year Study of an Investigational Drug in Obese Patients (0557-011)
NCT00092859 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00092859 |
|---|---|
| Title | A 2-Year Study of an Investigational Drug in Obese Patients (0557-011) |
| Official title | A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety, Tolerability, and Efficacy of MK0557 in Obese Patients |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Obesity |
| Intervention type | Drug |
| Interventions | MK0557 |
| Enrollment | 1,500 |
| Start date | Aug 1, 2003 |
| Primary completion | Jun 1, 2005 |
| Completion | Jun 1, 2005 |
| First posted | Sep 28, 2004 |
| Last update posted | Jan 2, 2017 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: